Home Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research
 

Keywords :   


Medidata's Risk-Based Monitoring Solution Selected By Infinity Pharmaceuticals To Advance Oncology Research

2015-11-25 01:19:03| drugdiscoveryonline Home Page

Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that Infinity Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the discovery, development and delivery of medicines for difficult-totreat diseases, has expanded its use of the Medidata Clinical Cloud.

Tags: research selected solution advance

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Kim Madigan to chair 2025 FTA Fall Technical Conference
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »